Clinical Trials on Ocular Surface Cicatrizing Diseases in Sweden

Total 58 results

Karolinska Institutet

Recruiting

Domiciliary Professional Oral Care for Dependent Older Adults (HET)

Aging | Dental Caries of Root Surface

Sweden
St. Erik Eye Hospital

Completed

Impact of Self-tonometry on Glaucoma Treatment Decision.

Glaucoma | Glaucoma, Open-Angle | OHT - Ocular Hypertension | Glaucoma Capsulare

Sweden
St. Erik Eye Hospital

Terminated

Antisecretory Factor (AF) Effects on Intraocular-pressure

Glaucoma

Sweden
Umeå University
Karolinska Institutet; Lund University; Göteborg University; Linkoeping University and other collaborators

Recruiting

The Glaucoma Nicotinamide Trial (TGNT)

Glaucoma

Sweden
Umeå University

Completed

Nicotinamide and Glaucoma

Glaucoma

Sweden
Umeå University

Unknown

Blood Flow of Ophthalmic Artery and Glaucoma

Glaucoma

Sweden
Vastra Gotaland Region

Recruiting

The Sahlgrenska Anti-VEGF Study (SAHLVE)

Neovascular Age-related Macular Degeneration

Sweden
Anders Kvanta

Completed

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

Neovascular Age-related Macular Degeneration

Sweden
Umeå University
Västerbotten County Council, Sweden

Completed

Pressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma.

Normal Tension Glaucoma

Sweden
Bayer
Regeneron Pharmaceuticals

Completed

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting (INSIGHT)

Wet Macular Degeneration

Sweden
University Hospital, Linkoeping

Completed

Prophylactic Laser Treatment of Drusen Maculopathy

Age-related Macular Degeneration

Sweden
St. Erik Eye Hospital

Withdrawn

The Avastin vs Visudyne for Neovascular AMD Study

Age-related Macular Degeneration

Sweden
National Eye Institute (NEI)

Unknown

Early Manifest Glaucoma Trial (EMGT)

Open-Angle Glaucoma

Sweden
St. Erik Eye Hospital

Completed

Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension

Age-related Macular Degeneration

Sweden
St. Erik Eye Hospital

Terminated

IOP Monitoring After Trabeculectomy Using iCare Home

Glaucoma, Open-Angle | Pseudo Exfoliation Syndrome

Sweden
St. Erik Eye Hospital

Unknown

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion With Macular Edema

Sweden
St. Erik Eye Hospital

Completed

iCare® Home vs Goldmann Applanation Tonometry

Ocular Hypertension | Glaucoma | Open Angle Glaucoma | Pseudo Exfoliation Syndrome

Sweden
Göteborg University

Completed

Genetic and Risk Factors in Exfoliation Glaucoma Patients

Genetic Predisposition to Disease | Risk Reduction | Glaucoma Capsulare

Sweden
Umeå University

Active, not recruiting

Swedish Microinvasive Glaucoma Surgery Study (SMIGS) (SMIGS)

Cataract | Open Angle Glaucoma | MIGS | Kahook Dual Blade Glide | Istent Inject W | Goniotomy

Sweden
Jan Calissendorff

Recruiting

Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

Hyperthyroidism

Sweden
St. Erik Eye Hospital

Recruiting

Monitoring of the IOP After SLT Using iCare Home

Pseudo Exfoliation Syndrome | Glaucoma Open-Angle Primary

Sweden
Vastra Gotaland Region
Göteborg University

Enrolling by invitation

Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial (OSLT-R)

Ocular Hypertension | Glaucoma, Open-Angle | Pseudoexfoliation Glaucoma

Sweden
St. Erik Eye Hospital

Unknown

TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration

Choroidal Neovascularization

Sweden
Vastra Gotaland Region
Göteborg University

Enrolling by invitation

Uddevalla Skövde Transscleral Micropulse Study (USTMS)

Primary Open Angle Glaucoma | Pseudoexfoliation Glaucoma

Sweden
Vastra Gotaland Region
Göteborg University

Active, not recruiting

Optimal Treatment Protocol for Selective Laser Trabeculoplasty (OSLT)

Ocular Hypertension | Glaucoma, Open-Angle | Pseudoexfoliation Glaucoma

Sweden
AstraZeneca

Completed

A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure

Raised Intraocular Pressure

Sweden, United States, United Kingdom
Allergan

Completed

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Macular Edema | Retinal Vein Occlusion

Denmark, Norway, Sweden
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia

Ocular Hypertension | Open Angle Glaucoma

Sweden, Norway, Denmark, Finland
Mantis Photonics AB
Sundets Ögonläkare

Enrolling by invitation

Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera

Macular Degeneration | Retinal Detachment | Glaucoma Eye | Macula Abnormality

Sweden
Uppsala University
British Medical Research Council; Uppsala University Hospital

Completed

First-in-human Evaluation of [18F]CETO

Adrenocortical Carcinoma | Adrenal Cushing Syndrome | Primary Aldosteronism Due to Aldosterone Producing Adenoma | Primary Aldosteronism Due to Nodular Hyperplasia | Non-Secretory Adrenal Adenoma

Sweden
Bayer

Completed

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease (XTEND)

Wet Age-related Macular Degeneration

Canada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
Zimmer Biomet

Active, not recruiting

Persona Partial Knee Clinical Outcomes Study

Osteoarthritis | Avascular Necrosis | Traumatic Arthritis | Conditional Tibial Condyle or Plateau Fractures | Conditional Revision of the Articular Surface

United Kingdom, Spain, United States, Italy, Sweden, Belgium, Austria, France, Germany, Switzerland
Pfizer

Completed

Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.

Ocular Hypertension | Glaucoma, Open-Angle

Sweden, Finland
Bayer

Recruiting

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Visual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)

Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long-Term Non-Interventional Latanoprost Study (LYNX)

Ocular Hypertension | Glaucoma

Spain, Czechia, Sweden, Germany, France, Greece, Belgium, Colombia, Denmark, Italy, Peru, Portugal, Slovakia, United Kingdom
Skane University Hospital
AC Immune SA

Completed

Optimization of Morphomer-based Alpha-synuclein PET Tracers

Parkinson Disease | Multiple System Atrophy | Corticobasal Degeneration | Progressive Supranuclear Palsy | Dementia With Lewy Bodies

Sweden
Karolinska University Hospital
Umeå University

Enrolling by invitation

Pancreatic Cancer Initial Detection Via Liquid Biopsy (PANCAID)

Pancreatic Cancer | Chronic Pancreatitis | IPMN, Pancreatic | Individuals at Risk

Sweden
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema. (ARTES)

Diabetic Macular Edema

Spain, Portugal, Finland, France, Israel, Italy, Sweden, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

Ocular Hypertension | Glaucoma, Open Angle

Italy, France, Greece, Sweden, Germany
Skane University Hospital
Lund University

Recruiting

The Swedish BioFINDER 2 Study (BioFINDER2)

Parkinson Disease | Dementia | Alzheimer Disease | Frontotemporal Degeneration | Mild Cognitive Impairment | Lewy Body Disease | Multiple System Atrophy | Corticobasal Degeneration | Progressive Supranuclear Palsy | Semantic Dementia | Parkinson-Dementia Syndrome | Progressive Nonfluent Aphasia

Sweden
Pfizer

Completed

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Anti- VGF Inhibitor

Spain, United Kingdom, Finland, Sweden
Pfizer

Completed

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

France, Greece, Ireland, Spain, Sweden, United Kingdom, Belgium, Italy, Netherlands, Germany, Australia, Denmark
Novartis Pharmaceuticals

Completed

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD (SALT)

Neovascular Age-related Macular Degeneration

Germany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients

Ocular Hypertension | Glaucoma | Open-angle Glaucoma

Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration (OCTAVE)

Neovascular Age-related Macular Degeneration

Germany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
Novartis Pharmaceuticals

Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study (TALON Ext)

Neovascular Age-related Macular Degeneration

United States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
Novartis Pharmaceuticals

Completed

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications (PACIFIC)

Neovascular (Wet) Age-related Macular Degeneration

Germany, Switzerland, Netherlands
AbbVie

Active, not recruiting

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States, Argentina, Australia, Bulgaria, Czechia, Denmark, Germany, Hungary, Ireland, Italy, New Zealand, Poland, Russian Federation, South Africa, Sweden, United Kingdom
Novartis Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (KITE)

Diabetic Macular Edema

Czechia, India, Russian Federation, Taiwan, Turkey, Lebanon, Denmark, Estonia, France, Germany, Hungary, Korea, Republic of, Latvia, Lithuania, Bulgaria, Norway, Belgium, Malaysia, Sweden, Slovakia, Singapore, Poland, Switzerland
Pfizer

Completed

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Macular Degeneration

Greece, Italy, Slovakia, Spain, Sweden, Czech Republic, Germany, Belgium, France, Cyprus, Denmark, Ireland, Poland

Clinical Trials on Ocular Surface Cicatrizing Diseases in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations